Expression patterns of ER-α PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ

Ping Tang, Xi Wang, Linda Schiffhauer, Jianmin Wang, Patricia Bourne, Qi Yang, Andrew Quinn, Steven Hajdu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We have previously reported that high grade and non-high grade ductal carcinoma in situ (DCIS) of the breast can be subdivided into 3 cell origin subtypes (luminal, basal/stem, and null), and that high grade DCIS is more frequently associated with basal/stem cell subtypes compared to non-high grade DCIS. Here we refine the relationships between these 3 subtypes and the expression patterns of estrogen receptor-alpha (ER-α), progesterone receptor (PR), HER-2/neu, and epidermal growth factor receptor (ERFR) in 53 cases of non-high grade and 46 cases of high nuclear grade DCIS. Using a panel of antibodies to ER-α, PR, HER-2/neu, and EGFR, along with cytokeratin (CK) markers (CK5/6, CK8, CK14, CK17, and CK18), we found that all 3 cell origin subtypes can express ER-α and PR, and their expression is higher in non-high grade DCIS than in high grade DCIS; the expression of HER-2/neu is associated with luminal subtype only in non-high grade DCIS, but can be seen in all 3 subtypes in high grade DCIS; the expression of EGFR is low and is present only in luminal cell subtypes in both high and non-high grade DCIS. Basal/ stem cell and null cell subtypes occur in younger patients in non-high grade DCIS compared to high grade DCIS. In conclusion, the expression patterns of ER-α, PR, HER-2/neu, and EGFR are markedly different in different cell origin subtypes of both high grade and non-high grade DCIS, suggesting that cell origin subtypes as well as nuclear grade contribute to the biological and molecular heterogeneity of DCIS.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalAnnals of Clinical and Laboratory Science
Volume36
Issue number2
StatePublished - Mar 1 2006

Fingerprint

Carcinoma, Intraductal, Noninfiltrating
Estrogen Receptor alpha
Progesterone Receptors
Stem cells
Keratins
Epidermal Growth Factor Receptor
Antibodies
Stem Cells
Null Lymphocytes
Breast

Keywords

  • Breast cancer
  • Cell origin markers
  • Cytokeratins
  • Ductal carcinoma in situ
  • EGFR
  • ER-α
  • HER-2/neu
  • Nuclear grade
  • PR

ASJC Scopus subject areas

  • Microbiology
  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology
  • Molecular Biology
  • Hematology
  • Clinical Biochemistry
  • Medical Laboratory Technology

Cite this

Expression patterns of ER-α PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ. / Tang, Ping; Wang, Xi; Schiffhauer, Linda; Wang, Jianmin; Bourne, Patricia; Yang, Qi; Quinn, Andrew; Hajdu, Steven.

In: Annals of Clinical and Laboratory Science, Vol. 36, No. 2, 01.03.2006, p. 137-143.

Research output: Contribution to journalArticle

Tang, Ping ; Wang, Xi ; Schiffhauer, Linda ; Wang, Jianmin ; Bourne, Patricia ; Yang, Qi ; Quinn, Andrew ; Hajdu, Steven. / Expression patterns of ER-α PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ. In: Annals of Clinical and Laboratory Science. 2006 ; Vol. 36, No. 2. pp. 137-143.
@article{d5a9a227f16b46a1a80df5e1b6ea19ae,
title = "Expression patterns of ER-α PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ",
abstract = "We have previously reported that high grade and non-high grade ductal carcinoma in situ (DCIS) of the breast can be subdivided into 3 cell origin subtypes (luminal, basal/stem, and null), and that high grade DCIS is more frequently associated with basal/stem cell subtypes compared to non-high grade DCIS. Here we refine the relationships between these 3 subtypes and the expression patterns of estrogen receptor-alpha (ER-α), progesterone receptor (PR), HER-2/neu, and epidermal growth factor receptor (ERFR) in 53 cases of non-high grade and 46 cases of high nuclear grade DCIS. Using a panel of antibodies to ER-α, PR, HER-2/neu, and EGFR, along with cytokeratin (CK) markers (CK5/6, CK8, CK14, CK17, and CK18), we found that all 3 cell origin subtypes can express ER-α and PR, and their expression is higher in non-high grade DCIS than in high grade DCIS; the expression of HER-2/neu is associated with luminal subtype only in non-high grade DCIS, but can be seen in all 3 subtypes in high grade DCIS; the expression of EGFR is low and is present only in luminal cell subtypes in both high and non-high grade DCIS. Basal/ stem cell and null cell subtypes occur in younger patients in non-high grade DCIS compared to high grade DCIS. In conclusion, the expression patterns of ER-α, PR, HER-2/neu, and EGFR are markedly different in different cell origin subtypes of both high grade and non-high grade DCIS, suggesting that cell origin subtypes as well as nuclear grade contribute to the biological and molecular heterogeneity of DCIS.",
keywords = "Breast cancer, Cell origin markers, Cytokeratins, Ductal carcinoma in situ, EGFR, ER-α, HER-2/neu, Nuclear grade, PR",
author = "Ping Tang and Xi Wang and Linda Schiffhauer and Jianmin Wang and Patricia Bourne and Qi Yang and Andrew Quinn and Steven Hajdu",
year = "2006",
month = "3",
day = "1",
language = "English (US)",
volume = "36",
pages = "137--143",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "2",

}

TY - JOUR

T1 - Expression patterns of ER-α PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ

AU - Tang, Ping

AU - Wang, Xi

AU - Schiffhauer, Linda

AU - Wang, Jianmin

AU - Bourne, Patricia

AU - Yang, Qi

AU - Quinn, Andrew

AU - Hajdu, Steven

PY - 2006/3/1

Y1 - 2006/3/1

N2 - We have previously reported that high grade and non-high grade ductal carcinoma in situ (DCIS) of the breast can be subdivided into 3 cell origin subtypes (luminal, basal/stem, and null), and that high grade DCIS is more frequently associated with basal/stem cell subtypes compared to non-high grade DCIS. Here we refine the relationships between these 3 subtypes and the expression patterns of estrogen receptor-alpha (ER-α), progesterone receptor (PR), HER-2/neu, and epidermal growth factor receptor (ERFR) in 53 cases of non-high grade and 46 cases of high nuclear grade DCIS. Using a panel of antibodies to ER-α, PR, HER-2/neu, and EGFR, along with cytokeratin (CK) markers (CK5/6, CK8, CK14, CK17, and CK18), we found that all 3 cell origin subtypes can express ER-α and PR, and their expression is higher in non-high grade DCIS than in high grade DCIS; the expression of HER-2/neu is associated with luminal subtype only in non-high grade DCIS, but can be seen in all 3 subtypes in high grade DCIS; the expression of EGFR is low and is present only in luminal cell subtypes in both high and non-high grade DCIS. Basal/ stem cell and null cell subtypes occur in younger patients in non-high grade DCIS compared to high grade DCIS. In conclusion, the expression patterns of ER-α, PR, HER-2/neu, and EGFR are markedly different in different cell origin subtypes of both high grade and non-high grade DCIS, suggesting that cell origin subtypes as well as nuclear grade contribute to the biological and molecular heterogeneity of DCIS.

AB - We have previously reported that high grade and non-high grade ductal carcinoma in situ (DCIS) of the breast can be subdivided into 3 cell origin subtypes (luminal, basal/stem, and null), and that high grade DCIS is more frequently associated with basal/stem cell subtypes compared to non-high grade DCIS. Here we refine the relationships between these 3 subtypes and the expression patterns of estrogen receptor-alpha (ER-α), progesterone receptor (PR), HER-2/neu, and epidermal growth factor receptor (ERFR) in 53 cases of non-high grade and 46 cases of high nuclear grade DCIS. Using a panel of antibodies to ER-α, PR, HER-2/neu, and EGFR, along with cytokeratin (CK) markers (CK5/6, CK8, CK14, CK17, and CK18), we found that all 3 cell origin subtypes can express ER-α and PR, and their expression is higher in non-high grade DCIS than in high grade DCIS; the expression of HER-2/neu is associated with luminal subtype only in non-high grade DCIS, but can be seen in all 3 subtypes in high grade DCIS; the expression of EGFR is low and is present only in luminal cell subtypes in both high and non-high grade DCIS. Basal/ stem cell and null cell subtypes occur in younger patients in non-high grade DCIS compared to high grade DCIS. In conclusion, the expression patterns of ER-α, PR, HER-2/neu, and EGFR are markedly different in different cell origin subtypes of both high grade and non-high grade DCIS, suggesting that cell origin subtypes as well as nuclear grade contribute to the biological and molecular heterogeneity of DCIS.

KW - Breast cancer

KW - Cell origin markers

KW - Cytokeratins

KW - Ductal carcinoma in situ

KW - EGFR

KW - ER-α

KW - HER-2/neu

KW - Nuclear grade

KW - PR

UR - http://www.scopus.com/inward/record.url?scp=33646529150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646529150&partnerID=8YFLogxK

M3 - Article

C2 - 16682508

AN - SCOPUS:33646529150

VL - 36

SP - 137

EP - 143

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 2

ER -